These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25557298)

  • 21. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.
    Rubsamen PE; Davis PA; Hernandez E; O'Grady GE; Cousins SW
    Arch Ophthalmol; 1994 Mar; 112(3):407-13. PubMed ID: 8129669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evaluation of a biodegradable donut-shaped minitablet for prolonged posterior segment drug delivery in the rabbit eye model.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; Meyer LC; Du Toit LC; Naylor S; Wanblad C
    J Pharm Sci; 2011 May; 100(5):1819-32. PubMed ID: 21374617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
    Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
    J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of thalidomide-loaded biodegradable devices and evaluation of the effect on inhibition of inflammation and angiogenesis after subcutaneous application.
    Pereira BG; Batista LF; de Souza PA; da Silva GR; Andrade SP; Serakides R; da Nova Mussel W; Silva-Cunha A; Fialho SL
    Biomed Pharmacother; 2015 Apr; 71():21-8. PubMed ID: 25960210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of 5-fluorouracil polyactic acid microsphere in prevention of proliferative vitreoretinopathy].
    Bi HS; Cui Y; Zhang JH; Wang XR; Xie XF
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):37-41. PubMed ID: 16638279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathological and ophthalmoscopic evaluation of apocynin on experimental proliferative vitreoretinopathy in rabbit eyes.
    Ozer MA; Polat N; Ozen S; Ogurel T; Parlakpinar H; Vardi N
    Int Ophthalmol; 2017 Jun; 37(3):599-605. PubMed ID: 27495951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasonographical assessment of implanted biodegradable device for long-term slow release of methotrexate into the vitreous.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Correa ZM
    Exp Eye Res; 2016 Jul; 148():30-32. PubMed ID: 27181224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.
    Zhou T; Lewis H; Foster RE; Schwendeman SP
    J Control Release; 1998 Nov; 55(2-3):281-95. PubMed ID: 9795083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance.
    Grayson AC; Cima MJ; Langer R
    Biomaterials; 2005 May; 26(14):2137-45. PubMed ID: 15576189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustainable release of carmustine from biodegradable poly[((D,L))-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies.
    Tseng YY; Liao JY; Chen WA; Kao YC; Liu SJ
    Expert Opin Drug Deliv; 2013 Jul; 10(7):879-88. PubMed ID: 23289446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.
    Fernandes-Cunha GM; Fialho SL; da Silva GR; Silva-Cunha A; Zhao M; Behar-Cohen F
    Pharm Res; 2017 May; 34(5):1083-1092. PubMed ID: 28224388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a biodegradable antibiotic delivery system.
    Lin SS; Ueng SW; Liu SJ; Chan EC; Chao EK; Tsai CH; Chen KT; Wei FC; Shih CH
    Clin Orthop Relat Res; 1999 May; (362):240-50. PubMed ID: 10335303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriers.
    Guidetti B; Azéma J; Malet-Martino M; Martino R
    Curr Drug Deliv; 2008 Jan; 5(1):7-19. PubMed ID: 18220546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A biodegradable filament for controlled drug delivery.
    Mack BC; Wright KW; Davis ME
    J Control Release; 2009 Nov; 139(3):205-11. PubMed ID: 19567255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye.
    Zhang J; Sun H; Zhou N; Zhang B; Ma J
    Curr Eye Res; 2017 Dec; 42(12):1597-1603. PubMed ID: 29111828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manufacturing of Dexamethasone-Poly(d,l-Lactide-co-Glycolide) Implants Using Hot-Melt Extrusion: Within- and Between-Batch Product Performance Comparisons.
    Kelley RA; Ghaffari A; Wang Y; Choi S; Taylor JR; Hartman RR; Kompella UB
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):290-297. PubMed ID: 32330403
    [No Abstract]   [Full Text] [Related]  

  • 39. Osseointegration of anodized titanium implants coated with poly(lactide-co-glycolide)/basic fibroblast growth factor by electrospray.
    Lee SY; Koak JY; Heo SJ; Kim SK; Lee SJ; Nam SY
    Int J Oral Maxillofac Implants; 2010; 25(2):315-20. PubMed ID: 20369090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone--an in vivo study.
    Peng YJ; Kau YC; Wen CW; Liu KS; Liu SJ
    J Biomed Mater Res A; 2010 Aug; 94(2):426-32. PubMed ID: 20186737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.